Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1974 1
1980 2
1981 1
1983 3
1985 5
1986 1
1987 7
1988 5
1989 3
1990 4
1991 7
1992 12
1993 11
1994 20
1995 19
1996 26
1997 33
1998 27
1999 53
2000 58
2001 48
2002 49
2003 78
2004 90
2005 151
2006 184
2007 212
2008 237
2009 261
2010 317
2011 343
2012 422
2013 469
2014 536
2015 602
2016 613
2017 701
2018 800
2019 929
2020 1101
2021 1276
2022 1461
2023 1297
2024 1516
2025 1347
2026 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

13,835 results

Results by year

Filters applied: . Clear all
Page 1
The X-Age Project to construct a Chinese aging clock.
Li J, Jiang M, Wang Q, Zheng Z, Shen J, Li J, Xiong M, Zheng Y, Lu X, Cai Y, Fan Y, Geng L, Ji Q, Peng Q, Sun S, Wang Y, Xin Z, Yan K, Yang Y, Yu J, Yan H, Ai D, Bai Y, Bi Y, Bian XW, Bu P, Cai JP, Cao CM, Cao F, Cao Z, Chai R, Chan P, Chen C, Chen CS, Chen C, Chen D, Chen HZ, Chen L, Chen Q, Chen X, Chen X, Chen Y, Chen ZJ, Ci W, Dai Z, Ding Q, Dong B, Dong J, Fan JG, Feng S, Feng X, Feng Y, Fu X, Fu X, Gao F, Gao J, Gao Q, Gao S, Gu Y, Guan Y, Guo F, Han JJ, Hao H, Hao J, He F, He J, He M, He M, He Q, He Z, He Z, Hong H, Hong J, Hou S, Hu C, Hu P, Hu Z, Huang C, Huang J, Huang K, Huang P, Ji X, Ji Y, Jia S, Jiang H, Jiang W, Jin L, Jin ZB, Ju S, Ju Z, Kong QP, Kong W, Kong WJ, Kong X, Lei G, Li GL, Li J, Li J, Li M, Li R, Li W, Li W, Li XJ, Li X, Liang Q, Liang Z, Lin H, Liu B, Liu CY, Liu C, Liu F, Liu J, Liu JP, Liu K, Liu L, Liu P, Liu Q, Liu Q, Liu T, Liu W, Liu X, Liu Y, Liu Y, Liu Y, Liu Y, Liu Z, Long X, Lu Y, Luo J, Luo X, Ma C, Ma S, Ma X, Mao J, Mao Z, Ng SC, Nie G, Niu Y, Peng Y, Pu J, Qi J, Qiang L, Qiao J, Qin Y, Qu A, Qu J, Ren J, Ren R, Ruan XZ, Shi A, Shi H, Shi J, So KF, Song M, Song W, Songyang Z, Su J, Sun A, Sun L, Sun Q, Sun YE, Sun Y, Tang P, Tang QQ, Tang … See abstract for full author list ➔ Li J, et al. Among authors: yan l. Nat Aging. 2025 Sep;5(9):1669-1685. doi: 10.1038/s43587-025-00935-w. Epub 2025 Sep 9. Nat Aging. 2025. PMID: 40926127 Review.
Gender Disparities in the Association Between Educational Attainment and Cardiovascular-Kidney-Metabolic Syndrome: Cross-Sectional Study.
Ding Y, Wu X, Cao Q, Huang J, Xu X, Jiang Y, Huo Y, Wan Q, Qin Y, Hu R, Shi L, Su Q, Yu X, Yan L, Qin G, Tang X, Chen G, Xu M, Wang T, Zhao Z, Gao Z, Wang G, Shen F, Luo Z, Chen L, Li Q, Ye Z, Zhang Y, Liu C, Wang Y, Yang T, Deng H, Chen L, Zeng T, Zhao J, Mu Y, Wu S, Chen Y, Lu J, Wang W, Ning G, Xu Y, Bi Y, Li M. Ding Y, et al. Among authors: yan l. JMIR Public Health Surveill. 2024 Aug 23;10:e57920. doi: 10.2196/57920. JMIR Public Health Surveill. 2024. PMID: 39177971 Free PMC article.
Durvalumab with or without bevacizumab with transarterial chemoembolisation in hepatocellular carcinoma (EMERALD-1): a multiregional, randomised, double-blind, placebo-controlled, phase 3 study.
Sangro B, Kudo M, Erinjeri JP, Qin S, Ren Z, Chan SL, Arai Y, Heo J, Mai A, Escobar J, Lopez Chuken YA, Yoon JH, Tak WY, Breder VV, Suttichaimongkol T, Bouattour M, Lin SM, Peron JM, Nguyen QT, Yan L, Chiu CF, Santos FA, Veluvolu A, Thungappa SC, Matos M, Żotkiewicz M, Udoye SI, Kurland JF, Cohen GJ, Lencioni R; EMERALD-1 Investigators. Sangro B, et al. Among authors: yan l. Lancet. 2025 Jan 18;405(10474):216-232. doi: 10.1016/S0140-6736(24)02551-0. Epub 2025 Jan 8. Lancet. 2025. PMID: 39798579 Free PMC article. Clinical Trial.
Recaticimab Monotherapy for Nonfamilial Hypercholesterolemia and Mixed Hyperlipemia: The Phase 3 REMAIN-1 Randomized Trial.
Xu M, Wang Z, Zhang Y, Liu Y, Huang R, Han X, Yao Z, Sun J, Tian F, Hu X, Ma L, Lai C, Zhang X, Sheng J, Han Q, Jin C, Luo L, Zhao R, Li L, Xu B, Yin D, Luo S, Ge X, Liu Z, Yang P, Huang Z, Li T, Feng W, Wu Y, Ling Z, Ma L, Lv C, Deng C, Wei W, Wang Y, Yan L, Ge J; REMAIN-1 Investigators. Xu M, et al. Among authors: yan l. J Am Coll Cardiol. 2024 Nov 12;84(20):2026-2036. doi: 10.1016/j.jacc.2024.07.035. Epub 2024 Oct 9. J Am Coll Cardiol. 2024. PMID: 39387764 Clinical Trial.
13,835 results
You have reached the last available page of results. Please see the User Guide for more information.